{
    "pmcid": "10833066",
    "qa_pairs": {
        "How does the NanoLAS database enhance user interaction and data retrieval according to the summary?": [
            "By providing a visually appealing and easy-to-navigate interface.",
            "By offering a text-only interface for faster loading times.",
            "By requiring users to download data for offline analysis.",
            "By limiting access to only registered researchers."
        ],
        "What are some of the data sources integrated into the NanoLAS database?": [
            "RCSB PDB, SdAb-DB, Opig-SAbDab, and NCBI Virus database.",
            "PubMed, ClinicalTrials.gov, and WHO databases.",
            "FDA, EMA, and CDC databases.",
            "Google Scholar, ResearchGate, and Academia.edu."
        ],
        "What is the primary purpose of the NanoLAS database as described in the summary?": [
            "To overcome the limitations of existing nanobody databases by integrating and standardizing data from various sources.",
            "To provide a platform exclusively for the development of cancer therapies using nanobodies.",
            "To serve as a repository for all types of antibodies, not just nanobodies.",
            "To focus solely on the commercialization of nanobody-based products."
        ],
        "What therapeutic applications of nanobodies are highlighted in the summary?": [
            "Cancer treatment and COVID-19 therapies.",
            "Diabetes management and cardiovascular disease treatment.",
            "Neurological disorder therapies and autoimmune disease management.",
            "Antibiotic resistance and bacterial infection treatments."
        ],
        "Which specific feature of nanobodies makes them particularly advantageous for therapeutic and diagnostic applications?": [
            "Their small size allows for superior tissue penetration.",
            "Their ability to bind to multiple antigens simultaneously.",
            "Their high immunogenicity compared to traditional antibodies.",
            "Their requirement for a secondary antibody for detection."
        ]
    }
}